MED Should I Buy

Not a good buy right now. MED is showing a weakening technical setup near support with no proprietary buy signals, deteriorating Q3’25 fundamentals (sharp revenue decline and losses), and a bearish short-term pattern outlook. For an impatient investor who doesn’t want to wait for a cleaner entry, the risk/reward is unfavorable at ~$11.15—this is an avoid/sell today.

Trend/price action: Price at 11.15 is sitting just below the S1 support zone (S1: 11.188) with the next support at S2: 10.926. Resistance is overhead at Pivot 11.612 then R1 12.036, meaning upside is capped quickly unless momentum flips. Momentum: MACD histogram (-0.0321) is below zero and negatively expanding, signaling bearish momentum is strengthening. RSI: RSI_6 ~31.96 is near oversold-ish territory but still labeled neutral here—this can bounce, but it’s not a reliable buy trigger given the bearish MACD. Moving averages: Converging MAs suggest indecision/attempted base, but the momentum signals do not confirm a durable reversal. Quant pattern read-through: Similar-pattern stats imply elevated downside risk (next week -14.75% probability/expectation style signal; next month -12.18%), which argues against chasing a bottom. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today.